Pepvise
Imprint

Editorial Standards

PepVise publishes educational content about GLP-1 medications. The reader trust we need to earn is different from other health-adjacent sites, so our rules are stricter. Here's how we work.

We are not a clinic

Nothing on this site is medical advice. We describe what studies, FDA labels, manufacturer documents, and peer-reviewed papers have published. We do not diagnose, treat, cure, or prevent any disease or condition. Always consult your healthcare provider before starting, stopping, or changing any medication.

Sourcing

Every factual claim about a specific drug, dose, or side effect on this site is cited to one of:

  • An FDA-approved prescribing information document (the label)
  • A peer-reviewed trial published in an indexed medical journal
  • A manufacturer's public technical document
  • A regulatory or government document (FDA, EMA, CDC, NIH)

For any significant health claim, we prefer two independent sources , one primary study plus one regulatory or manufacturer reference. When evidence is genuinely mixed, we say so in the text. We don't pretend to have certainty we don't have.

Use of generic and brand names

We always use the generic name alongside any brand name in the first mention of a post. “Tesamorelin (Egrifta)” and “sermorelin (Geref)”, always both. This is for accuracy and for accessibility when readers are comparing what their clinician has cited against what we've written.

No telehealth recommendations

We describe the telehealth landscape neutrally when relevant. We do not recommend specific telehealth providers. We will never link a reader to a telehealth clinic for commercial purposes.

Corrections

When we're wrong, we want to know. When we fix a factual error, we:

  1. Correct the text
  2. Add a dated correction note at the bottom of the post
  3. Don't silently edit, the history stays visible

Email corrections to hello@pepvise.com. We respond within 5 business days.

Conflicts of interest

PepVise does not accept payment from drug manufacturers. PepVise does not accept payment from telehealth clinics in exchange for editorial coverage. When we link to a supplement brand (protein powder, electrolytes, fiber) we may earn an affiliate commission, and we disclose it on every page where it applies, above the product list, in plain English.

AI and our editorial process

We use AI tools in parts of our workflow, literature synthesis, draft generation, grammar checks, formatting. Every post on this site is reviewed, fact-checked, and edited by a human before publication. No post is published that hasn't been through that review.

When AI tooling is used in a way that materially shapes a post's conclusions, we say so explicitly.

Images and privacy

We do not publish before/after photos, weight-loss numbers, or body-focused imagery. These are platform compliance landmines, and they invite the wrong reader.

What we don't do

  • We don't accept payment for editorial placement
  • We don't publish content written by drug manufacturers
  • We don't use words like “miracle,” “secret,” or “shocking”
  • We don't write fake urgency, fake scarcity, or fake reviews
  • We don't tell readers to start or stop any medication

Last updated: April 2026.